[Leptomeningeal carcinosis--new diagnostic possibilities by tumor cell marking with monoclonal antibodies].
Pfadenhauer
K
K
Neurologische Klinik mit Klinischer Neurophysiologie, Zentralklinikum Augsburg.
Schlimok
G
G
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal; D001943:Breast Neoplasms / Q000473:pathology*; D002555:Cerebrospinal Fluid / Q000166:cytology; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007633:Keratins / Q000276:immunology; D008175:Lung Neoplasms / Q000473:pathology*; D008297:Male; D008577:Meningeal Neoplasms / Q000473:pathology / Q000556:secondary*; D008578:Meninges / Q000473:pathology*; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000473:pathology*
D000911:Antibodies, Monoclonal; D007633:Keratins
Leptomeningealkarzinose--neue diagnostische Möglichkeiten durch Tumorzellmarkierung mit monoklonalen Antikörpern.